2 Paul Tudor Jones II Humacyte Trades
Paul Tudor Jones II started to build up the position in Humacyte in Q2 2024. Since then they sold 12.2 Thousand shares. The investor sold all their shares in Q3 2024 and doesn't own any shares in Humacyte anymore.
Avg closing price
Price range
Sold -12.2 Thousand shares
Q3 2024
Avg closing price
$6.45
Price range
$5.11
-
$9.46
New holding (+12.2 Thousand shares)
Q2 2024
Avg closing price
$5.20
Price range
$2.87
-
$9.10
News about Humacyte Inc and Paul Tudor Jones II
Humacyte Stockholders Elect Directors and Ratify Auditor at Annual Meeting
Humacyte (HUMA) just unveiled an announcement. At Humacyte, Inc.’s 2024 Annual Meeting, stockholders elected six Class III directors and confirmed …
Huma receives world''s first and only multi-condition EU MDR Class IIb regulatory approval for its configurable SaMD disease management platform